RIYADH, SAUDI ARABIA — A 49-year-old woman is on the mend after developing a disturbing post-injection immune-mediated skin disorder. Researchers at the Prince Mohammed Bin Abdulaziz Hospital in Riyadh published their peer-reviewed case study last week. The unnamed woman went to the emergency room one week after receiving the first dose of experimental Pfizer mRNA. They describe the case as follows:
|
Friday, August 27, 2021
Toxic epidermal necrolysis: 49-year-old New York woman develops life-threatening skin-rotting disorder one week after Pfizer mRNA injection
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment